You are here

Inovio

Inovio’s reinvention falls flat

Inovio’s reinvention falls flat

EP Vantage

cancer vaccines

Flag link:

Clinical developments over the holidays

Clinical developments over the holidays

EP Vantage

Aprea Therapeutics

Arcturus Therapeutics

Axsome Therapeutics

clinical trials

Flag link:

Inovio doses first patient in phase 2 segment of Covid-19 DNA vaccine candidate trial

Inovio doses first patient in phase 2 segment of Covid-19 DNA vaccine candidate trial

Pharmaceutical Business Review

clinical trials

Flag link:

Inovio secures FDA nod for phase 2 segment of Covid-19 DNA vaccine candidate trial

Inovio secures FDA nod for phase 2 segment of Covid-19 DNA vaccine candidate trial

Pharmaceutical Business Review

clinical trials

Flag link:

Inovio Jumps on Progress of Coronavirus Vaccine Candidate

Inovio Jumps on Progress of Coronavirus Vaccine Candidate

TheStreet.com

clinical trials

Flag link:

Inovio Forced To Delay Planned Phase 2/3 Testing Of Covid-19 Vaccine; Stock Plummets

Inovio Forced To Delay Planned Phase 2/3 Testing Of Covid-19 Vaccine; Stock Plummets

Investors Business Daily

clinical trials

Flag link:

Which Biotech Company Has the Most Promising Coronavirus Vaccine?

Which Biotech Company Has the Most Promising Coronavirus Vaccine?

Motley Fool

Moderna Therapeutics

Flag link:

Here's Why Inovio Is The Front-Runner In Developing a Coronavirus Vaccine

Here's Why Inovio Is The Front-Runner In Developing a Coronavirus Vaccine

Motley Fool

Flag link:

Inovio claims positive results on Covid-19 vaccine but critical data are missing

Inovio claims positive results on Covid-19 vaccine but critical data are missing

Stat

clinical trials

Flag link:

Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device

Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device

Reuters

Department of Defense

Flag link:

The coronavirus vaccine frontrunners have emerged. Here's where they stand

The coronavirus vaccine frontrunners have emerged. Here's where they stand

BioPharma Dive

Moderna Therapeutics

Cansino Biologics

Oxford BioMedica

Flag link:

Is Moderna Really the Leader in the COVID-19 Vaccine Race?

Is Moderna Really the Leader in the COVID-19 Vaccine Race?

Motley Fool

Moderna Therapeutics

Flag link:

Caught in a standoff with its contract manufacturer over Covid-19 vaccine, Inovio files suit in an attempt to break free while rivals race ahead

Caught in a standoff with its contract manufacturer over Covid-19 vaccine, Inovio files suit in an attempt to break free while rivals race ahead

Endpoints

Flag link:

Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

Yahoo/Benzinga

University of Oxford

Moderna Therapeutics

Flag link:

Is Inovio Gaining Ground in the Coronavirus Vaccine Race?

Is Inovio Gaining Ground in the Coronavirus Vaccine Race?

Motley Fool

Moderna Therapeutics

clinical trials

Flag link:

Inovio's COVID-19 vaccine claims echo Theranos, says short attack

Inovio's COVID-19 vaccine claims echo Theranos, says short attack

Fierce Pharma

Citron Research

Flag link:

Inovio Ramps Up Production of Its Coronavirus Vaccine Candidate

Inovio Ramps Up Production of Its Coronavirus Vaccine Candidate

Motley Fool

drug manufacturing

Flag link:

Don't count on a COVID-19 vaccine for at least 5 years, says AI-based forecast

Don't count on a COVID-19 vaccine for at least 5 years, says AI-based forecast

Fierce Pharma

Clarivate Analytics

artificial intelligence

Moderna Therapeutics

Flag link:

5 Biotech Stocks Winning the Coronavirus Race

5 Biotech Stocks Winning the Coronavirus Race

Motley Fool

drug development

Gilead Sciences

Moderna Therapeutics

Flag link:

The long path to an effective coronavirus vaccine

The long path to an effective coronavirus vaccine

EP Vantage

Moderna Therapeutics

Shenzhen Genoimmune

Cansino Biologics

Flag link:

Pages